These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2936009)

  • 1. Measurement of rat-intestinal cefuroxime axetil esterase activity: comparison of an h.p.l.c. and coupled-enzyme assay.
    Campbell CJ; Langley C
    Xenobiotica; 1985 Dec; 15(12):1011-9. PubMed ID: 2936009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esterase activity toward the diastereomers of cefuroxime axetil in the rat and dog.
    Mosher GL; McBee J; Shaw DB
    Pharm Res; 1992 May; 9(5):687-9. PubMed ID: 1608904
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of cefuroxime axetil in suspensions.
    Pramar Y; Das Gupta V; Bethea C; Zerai T
    J Clin Pharm Ther; 1991 Oct; 16(5):341-4. PubMed ID: 1752913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and partial characterization of rat intestinal cefuroxime axetil esterase.
    Campbell CJ; Chantrell LJ; Eastmond R
    Biochem Pharmacol; 1987 Jul; 36(14):2317-24. PubMed ID: 3606643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A stability indicating assay method for cefuroxime axetil and its application to analysis of tablets exposed to accelerated stability test conditions.
    Ivana I; Ljiljana Z; Mira Z
    J Chromatogr A; 2006 Jun; 1119(1-2):209-15. PubMed ID: 16445930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of diastereomer hydrolysis kinetics to shelf-life predictions for cefuroxime axetil.
    Nguyen NA
    Pharm Res; 1991 Jul; 8(7):893-8. PubMed ID: 1924141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stability of the amorphous form of cefuroxime axetil in solid state.
    Jelińska A; Dudzińska I; Zajac M; Oszczpowicz I
    J Pharm Biomed Anal; 2006 Jun; 41(3):1075-81. PubMed ID: 16563687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme A- and NADH-dependent esterase activity of methylmalonate semialdehyde dehydrogenase.
    Popov KM; Kedishvili NY; Harris RA
    Biochim Biophys Acta; 1992 Feb; 1119(1):69-73. PubMed ID: 1540637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the action features between cefuroxime axetil and bovine serum albumin].
    Wu GK; Yan CN; Liu Y
    Guang Pu Xue Yu Guang Pu Fen Xi; 2008 Sep; 28(9):2139-43. PubMed ID: 19093579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoisomerization kinetics of cefuroxime axetil and related compounds.
    Fabre H; Ibork H; Lerner DA
    J Pharm Sci; 1994 Apr; 83(4):553-8. PubMed ID: 8046613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability of cefuroxime axetil suspension formulations administered with food in healthy subjects.
    Mendes GD; Borges A; de Cássia Val L; Patni AK; Reyar S; Monif T; Sereno D; Orellana AM; De Nucci G
    Arzneimittelforschung; 2010; 60(2):101-5. PubMed ID: 20329659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
    Dantzig AH; Duckworth DC; Tabas LB
    Biochim Biophys Acta; 1994 Apr; 1191(1):7-13. PubMed ID: 8155686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of the safety of cefuroxime axetil during six months oral administration to beagle dogs.
    Spurling NW; Harcourt RA; Hyde JJ
    J Toxicol Sci; 1986 Nov; 11(4):237-77. PubMed ID: 3820342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stability of Cefuroxime axetil in tablets.
    Jelińska A; Dudzińska I; Zajac M; Oszczapowicz I; Krzewski W
    Acta Pol Pharm; 2005; 62(3):183-7. PubMed ID: 16193810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of alcohol dehydrogenase and ethanol oxidation in vivo and in hepatocytes.
    Cornell NW
    Pharmacol Biochem Behav; 1983; 18 Suppl 1():215-21. PubMed ID: 6356160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the kinetics and mechanism of yeast alcohol dehydrogenase with a variety of substrates.
    Dickinson FM; Monger GP
    Biochem J; 1973 Feb; 131(2):261-70. PubMed ID: 4352908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence evaluation of 2 brands of cefuroxime axetil 250 mg tablets in healthy human volunteers.
    Pistos C; Michalea S; Kalovidouris M; Kontopoulos G; Georgarakis M
    Int J Clin Pharmacol Ther; 2004 Jul; 42(7):367-72. PubMed ID: 15605688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
    Williams KJ; Hebblethwaite EM; Brown GW; Cox DM; Plested SJ
    Drugs Exp Clin Res; 1987; 13(2):95-9. PubMed ID: 3556123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans.
    Arnez M; Radsel-Medvescek A; Pleterski-Rigler D; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):916-22. PubMed ID: 10666802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
    Lang CC; Moreland TA; Davey PG
    J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.